Ming‐Jong Bair

Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients

Tung‐Hung Su, Tsung‐Hui Hu, Chi‐Yi Chen et al. · Liver International · 2016 · 217 citations

Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial

Jyh‐Ming Liou, Chieh‐Chang Chen, Chih‐Min Chang et al. · The Lancet Infectious Diseases · 2019 · 199 citations

Probiotic, Dysbiosis, Randomised Trial +9

The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors—A Nationwide Study

Jyh‐Ming Liou, Chi‐Yang Chang, Mei‐Jyh Chen et al. · PLoS ONE · 2015 · 86 citations · Full text

Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection

Jyh‐Ming Liou, Po‐Yueh Chen, Jiing‐Chyuan Luo et al. · Gastroenterology · 2018 · 81 citations

Antimicrobial Resistance Gene, Refractory Helicobacter, Health Sciences +8

Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of <i>Helicobacter pylori</i> in the community and hospital populations: a randomised trial

Jyh‐Ming Liou, Chieh‐Chang Chen, Chi‐Yang Chang et al. · Gut · 2015 · 78 citations · Full text